To uncover L1CAM-regulated signaling pathways, we employed quantitative proteomics and phosphoproteomics, which have become an indispensable tool for a deeper understanding of cancer biology and identification of clinically relevant pathways suitable for therapeutic intervention. This evidence concerns the gene L1CAM and cancer.